Diabetes, Obesity and Human Reproduction

Search for publications

Only original articles, editorials, guidelines.

  • Luque-Ramírez M, Escobar-Morreale HF.

    Targets to treat androgen excess in polycystic ovary syndrome

    EXPERT OPINION ON THERAPEUTIC TARGETS . 19(11, SI): 1545-1560. Number of citations: 8


  • Alpañés M, Luque-Ramírez M, Martínez-García MÁ, Fernández-Durán E, Álvarez-Blasco F, Escobar-Morreale HF.

    Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome

    FERTILITY AND STERILITY . 103(3): 795-519. Number of citations: 17


  • Escobar-Morreale, Hector F., Botella-Carretero, Jose I., Morreale de Escobar, Gabriella.

    Treatment of hypothyroidism with levothyroxine or a combination of levothyroxine plus L-triiodothyronine

    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM . 29(1): 57-75. Number of citations: 11


  • Borruel S, Moltó JF, Alpañés M, Fernández-Durán E, Álvarez-Blasco F, Luque-Ramírez M, Escobar-Morreale HF.

    Surrogate Markers of Visceral Adiposity in Young Adults: Waist Circumference and Body Mass Index Are More Accurate than Waist Hip Ratio, Model of Adipose Distribution and Visceral Adiposity Index

    Plos One . 9(12): e114112. Number of citations: 42


  • Luque-Ramírez M, Escobar-Morreale HF.

    Polycystic Ovary Syndrome as a Paradigm for Prehypertension, Prediabetes, and Preobesity

    CURRENT HYPERTENSION REPORTS . 16(12): 500-500. Number of citations: 25


  • Escobar-Morreale HF, Alvarez-Blasco F, Botella-Carretero JI, Luque-Ramírez M.

    The striking similarities in the metabolic associations of female androgen excess and male androgen deficiency

    HUMAN REPRODUCTION . 29(10): 2083-2091. Number of citations: 41


  • Conway G, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Franks S, Gambineri A, Kelestimur F, Macut D, Micic D, Pasquali R, Pfeifer M, Pignatelli D, Pugeat M, Yildiz BO.

    The polycystic ovary syndrome: a position statement from the European Society of Endocrinology

    EUROPEAN JOURNAL OF ENDOCRINOLOGY . 171(4): 1-29. Number of citations: 254


  • Conway G, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Franks S, Gambineri A, Kelestimur F, Macut D, Micic D, Pasquali R, Pfeifer M, Pignatelli D, Pugeat M, Yildiz B.

    European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group's Questionnaire

    EUROPEAN JOURNAL OF ENDOCRINOLOGY . 171(4): 489-498. Number of citations: 47


  • Calderón B, Galdón A, Calañas A, Peromingo R, Galindo J, García-Moreno F, Rodriguez-Velasco G, Martín-Hidalgo A, Vazquez C, Escobar-Morreale HF, Botella-Carretero JI.

    Effects of Bariatric Surgery on Male Obesity-Associated Secondary Hypogonadism: Comparison of Laparoscopic Gastric Bypass with Restrictive Procedures

    OBESITY SURGERY . 24(10): 1686-1692. Number of citations: 29


  • Murri M, Insenser M, Luque M, Tinahones FJ, Escobar-Morreale HF.

    Proteomic analysis of adipose tissue: informing diabetes research

    EXPERT REVIEW OF PROTEOMICS . 11(4): 491-502. Number of citations: 8


  • Insenser M, Montes-Nieto R, Martínez-García MÁ, Durán EF, Santiuste C, Gómez V, Kline JA, Escobar-Morreale HF, Jiménez D.

    Identification of Reduced Circulating Haptoglobin Concentration as a Biomarker of the Severity of Pulmonary Embolism: A Nontargeted Proteomic Study

    Plos One . 9(6): e100902. Number of citations: 9


  • Dewailly D, Lujan ME, Carmina E, Cedars MI, Laven J, Norman RJ, Escobar-Morreale HF.

    Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society

    HUMAN REPRODUCTION UPDATE . 20(3): 334-352. Number of citations: 191


  • Luque-Ramírez M, Martí D, Fernández-Durán E, Alpañés M, Álvarez-Blasco F, Escobar-Morreale HF.

    Office blood pressure, ambulatory blood pressure monitoring, and echocardiographic abnormalities in women with polycystic ovary syndrome: role of obesity and androgen excess.

    Hypertension . 63(3): 624-629. Number of citations: 17


  • Murri M, Insenser M, Escobar-Morreale HF.

    Metabolomics in polycystic ovary syndrome

    CLINICA CHIMICA ACTA . 429: 181-188. Number of citations: 22


  • Posada-González M, Gómez-Ramírez J, Luque-Ramírez M, Guijarro M, Martín-Pérez E, Rodríguez-Sánchez A, García-Sanz I, Larrañaga E.

    Nonfunctional Metastatic Parathyroid Carcinoma in the Setting of Multiple Endocrine Neoplasia Type 2A Syndrome.

    Surgery research and practice . 2014: 731481-731481.


  • Martínez-García MA, Capote F, Campos-Rodríguez F, Lloberes P, Díaz de Atauri MJ, Somoza M, Masa JF, González M, Sacristán L, Barbé F, Durán-Cantolla J, Aizpuru F, Mañas E, Barreiro B, Mosteiro M, Cebrián JJ, de la Peña M, García-Río F, Maimó A, Zapater J, Hernández C, Grau SanMarti N, Montserrat JM.

    Effect of CPAP on Blood Pressure in Patients With Obstructive Sleep Apnea and Resistant Hypertension The HIPARCO Randomized Clinical Trial

    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION . 310(22): 2407-2415. Number of citations: 304


  • Murri M, Insenser M, Fernández-Durán E, San-Millán JL, Escobar-Morreale HF.

    Effects of Polycystic Ovary Syndrome (PCOS), Sex Hormones, and Obesity on Circulating miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 Expression

    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM . 98(11): 1835-1844. Number of citations: 81


  • Insenser M, Escobar-Morreale HF.

    Proteomics and polycystic ovary syndrome

    EXPERT REVIEW OF PROTEOMICS . 10(5): 435-447. Number of citations: 13